Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.52 |
| ▸ | PPARA | Q07869 | 3/20 | 0.52 |
| ▸ | RELA | Q04206 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | XBP1 | P17861 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4998398 | 0.93 | RELA (0.58) | CA1PPARARELACA2CA12 | |
| SCHEMBL11515763 | 0.92 | CA1 (0.55) | CA1PPARARELACA2CA12 | |
| SCHEMBL14081786 | 0.91 | RELA (0.61) | CA1PPARARELACA2CA12 | |
| SCHEMBL7689617 | 0.91 | RELA (0.61) | CA1PPARARELACA2CA12 | |
| SCHEMBL608990 | 0.90 | CA1 (0.61) | CA1PPARARELACA2CA12 | |
| SCHEMBL7687552 | 0.88 | RELA (0.62) | CA1PPARARELACA2CA12 | |
| SCHEMBL7688965 | 0.86 | RELA (0.66) | CA1PPARARELACA2CA12 | |
| SCHEMBL1446467 | 0.86 | RELA (0.47) | CA1PPARARELACA2CA12 | |
| SCHEMBL10596044 | 0.86 | RELA (0.66) | CA1PPARARELACA2CA12 | |
| SCHEMBL10924903 | 0.86 | RELA (0.66) | CA1PPARARELACA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103582642-A | HSP90 inhibitors | SLOAN KETTERING INST CANCER | 2014-02-12 | — | — | CN | claimed |
| CN-119968127-A | Animal food compositions with improved palatability and customizable properties and methods of making the same | 玛氏公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-3892278-B1 | CYCLOALKANE-1,3-DIAMINE DERIVATIVE | DAIICHI SANKYO CO LTD (JP) | 2024-02-28 | — | — | EP | disclosed |
| US-20230074669-A1 | CYCLOALKANE-1,3-DIAMINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2023-03-09 | — | — | US | disclosed |
| US-20230030720-A1 | CYCLOALKANE-1,3-DIAMINE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2023-02-02 | — | — | US | disclosed |
| CN-109374889-B | Use of labeled HSP90 inhibitors | 索隆-基特林癌症研究协会 | 2022-04-19 | — | — | CN | disclosed |
| US-11236106-B2 | Cycloalkane-1,3-diamine derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2022-02-01 | — | — | US | disclosed |
| EP-3892278-A1 | CYCLOALKANE-1,3-DIAMINE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2021-10-13 | — | — | EP | disclosed |
| CN-103582642-A | HSP90 inhibitors | SLOAN KETTERING INST CANCER | 2014-02-12 | — | — | CN | disclosed |
| CN-100455565-C | Sulfonamide anions as catalysts for nco oligomerization | BAYER MATERIALSCIENCE AG (DE) | 2009-01-28 | — | — | CN | disclosed |
| EP-1654324-B1 | SULPHONAMIDE ANIONS AS CATALYSTS FOR NCO OLIGOMERISATION | BAYER MATERIALSCIENCE AG (DE) | 2006-12-27 | — | — | EP | disclosed |
| CN-1833003-A | Sulfonamide anions as catalysts for nco oligomerization | BAYER MATERIALSCIENCE AG (DE) | 2006-09-13 | — | — | CN | disclosed |
| US-7060817-B2 | Sulfonamide anions as catalysts for NCO oligomerization | BAYER MATERIALSCIENCE AG (DE) | 2006-06-13 | — | — | US | disclosed |
| EP-1654324-A1 | SULPHONAMIDE ANIONS AS CATALYSTS FOR NCO OLIGOMERISATION | Bayer MaterialScience AG (DE) | 2006-05-10 | — | — | EP | disclosed |
| WO-2005017037-A1 | SULPHONAMIDE ANIONS AS CATALYSTS FOR NCO OLIGOMERISATION | BAYER MATERIALSCIENCE AG (DE) | 2005-02-24 | — | — | WO | disclosed |
| US-20050033005-A1 | Sulfonamide anions as catalysts for NCO oligomerization | BAYER MATERIALSCIENCE AG (DE) | 2005-02-10 | — | — | US | disclosed |
| WO-2002000622-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11236106-B2 | Cycloalkane-1,3-diamine derivative | MLLT1, MEN1, MLLT3 | CA1 3083/4885PPARA 2779/4885RELA 1292/4885 |
| US-20230030720-A1 | CYCLOALKANE-1,3-DIAMINE DERIVATIVE | MLLT1, MEN1, MLLT3 | CA1 3083/4885PPARA 2779/4885RELA 1292/4885 |
| US-20230074669-A1 | CYCLOALKANE-1,3-DIAMINE DERIVATIVE | MLLT1, MEN1, MLLT3 | CA1 3083/4885PPARA 2779/4885RELA 1292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.